4
Changes in Ownership
Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-040723
CEO and CFO bought 5,000 shares at $10.17 ($50,838)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Patel Snehal CEO and CFO | 2023-11-10 | Purchase | +5,000 | $10.17 | $50,838 | 5,312,677 | D |
| Open-market purchases · 5,000 sh · avg $10.17 · $50,838 | |||||||
Loading xslF345X05/ownership.xml…